For the cohort of patients supplemented with vitamin D, PBMCs were analyzed with a panel of antibodies consisting of CD3-AF700, CD4-FITC, CD25-BV605, CD127-BV421, CD45RA-BV510, Foxp3-PE, CD46-PE/cy7, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback